Garyfalia Diamantopoulou

Dr. Garyfalia Diamantopoulou


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
EAELENA AVGOUSTOU
ELENA AVGOUSTOU
ITIlektra Tzivaki
Ilektra Tzivaki
GDGaryfalia Diamantopoulou
Garyfalia Diamantopoulou
TZTatiana Zachariadou
Tatiana Zachariadou
DADespoina Avramidou
Despoina Avramidou
ASAlexandros Skourtis
Alexandros Skourtis
Obesity has emerged as a global epidemic with far-reaching health complications, including its role as an independent risk factor for chronic kidney disease (CKD). Increasing evidence suggests that obesity contributes to CKD through multiple mechanisms, including chronic inflammation, hemodynamic alterations, insulin resistance, and lipid accumulation. These processes can culminate in histopathological changes collectively referred to as obesity-related glomerulopathy (ORG). This review aims to provide a comprehensive overview of the current knowledge regarding the prevalence, clinical manifestations, and pathophysiology of ORG. Furthermore, we emphasize the importance of identifying key biomarkers that facilitate the early detection of ORG. Finally, we explore emerging therapeutic strategies that offer promise in mitigating this growing global health crisis.